AI-Powered OncoRedox Colorectal Cancer Sensor

AI-Powered OncoRedox Colorectal Cancer Sensor

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide. Despite significant advancements in treatment and awareness campaigns, late-stage diagnosis continues to hinder survival outcomes. With five-year survival rates for localised...
Genetics and Bowel Cancer Risk

Genetics and Bowel Cancer Risk

While lifestyle and environmental factors play a significant role in the development of bowel cancer, there can also be a hereditary component in a small number of cases. Understanding these underlying genetic causes is essential for early diagnosis and intervention,...
Combat’s Upcoming HIVEC®-HEAT Study 2025

Combat’s Upcoming HIVEC®-HEAT Study 2025

We are proud to announce our upcoming HIVEC®-HEAT Study, which is set to commence enrolment in May 2025. This trial represents a major milestone in the search for effective and less aggressive forms of treatment for non-muscle invasive bladder cancer (NMIBC). The...